- Home
- ADAP vs NKSH Comparison
ADAP vs NKSH Comparison
Compare ADAP & NKSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- NKSH
- Stock Information
- Founded
- ADAP 2008
- NKSH 1891
- Country
- ADAP United Kingdom
- NKSH United States
- Employees
- ADAP N/A
- NKSH N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- NKSH Major Banks
- Sector
- ADAP Health Care
- NKSH Finance
- Exchange
- ADAP Nasdaq
- NKSH Nasdaq
- Market Cap
- ADAP 75.5M
- NKSH 163.0M
- IPO Year
- ADAP 2015
- NKSH N/A
- Fundamental
- Price
- ADAP $0.24
- NKSH $27.86
- Analyst Decision
- ADAP Buy
- NKSH Strong Buy
- Analyst Count
- ADAP 6
- NKSH 1
- Target Price
- ADAP $1.35
- NKSH $38.00
- AVG Volume (30 Days)
- ADAP 665.7K
- NKSH 18.3K
- Earning Date
- ADAP 08-11-2025
- NKSH 08-13-2025
- Dividend Yield
- ADAP N/A
- NKSH 5.58%
- EPS Growth
- ADAP N/A
- NKSH N/A
- EPS
- ADAP N/A
- NKSH 1.38
- Revenue
- ADAP $179,639,000.00
- NKSH $46,211,000.00
- Revenue This Year
- ADAP N/A
- NKSH N/A
- Revenue Next Year
- ADAP $35.48
- NKSH $5.93
- P/E Ratio
- ADAP N/A
- NKSH $19.57
- Revenue Growth
- ADAP 878.53
- NKSH 2.21
- 52 Week Low
- ADAP $0.20
- NKSH $23.75
- 52 Week High
- ADAP $1.48
- NKSH $33.37
- Technical
- Relative Strength Index (RSI)
- ADAP 38.54
- NKSH 57.25
- Support Level
- ADAP $0.24
- NKSH $26.25
- Resistance Level
- ADAP $0.26
- NKSH $26.88
- Average True Range (ATR)
- ADAP 0.02
- NKSH 0.74
- MACD
- ADAP -0.00
- NKSH 0.08
- Stochastic Oscillator
- ADAP 15.25
- NKSH 77.41
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.